- Report
- January 2022
- 125 Pages
Global
From €1368EUR$1,400USD£1,142GBP
€1954EUR$2,000USD£1,631GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- January 2022
- 60 Pages
Global
From €2702EUR$2,765USD£2,255GBP
€3859EUR$3,950USD£3,222GBP
- Report
- August 2022
- 113 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- October 2023
- 190 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- May 2023
- 213 Pages
Global
From €3112EUR$3,185USD£2,598GBP
€4446EUR$4,550USD£3,711GBP
- Report
- April 2023
- 160 Pages
Global
From €5861EUR$5,999USD£4,893GBP
- Report
- June 2022
- 53 Pages
Global
From €3903EUR$3,995USD£3,259GBP
- Report
- April 2020
- 153 Pages
Global
From €10743EUR$10,995USD£8,968GBP
- Report
- August 2022
Global
From €1163EUR$1,190USD£971GBP
- Report
- August 2022
United States
From €1895EUR$1,940USD£1,582GBP
- Drug Pipelines
- December 2022
- 34 Pages
Global
From €9766EUR$9,995USD£8,153GBP
- Report
- November 2020
- 265 Pages
Global
From €3908EUR$4,000USD£3,263GBP
- Report
- August 2023
- 121 Pages
North America
From €1466EUR$1,500USD£1,224GBP
- Report
- August 2023
- 134 Pages
Asia Pacific
From €1466EUR$1,500USD£1,224GBP
- Report
- August 2023
- 263 Pages
Global
From €3517EUR$3,600USD£2,936GBP
The Colon Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat colon cancer. These drugs are used to reduce the size of tumors, reduce the spread of cancer cells, and improve the quality of life for those affected by the disease. Commonly used drugs include chemotherapy, targeted therapy, and immunotherapy.
Chemotherapy drugs are used to kill cancer cells and stop them from growing. Targeted therapy drugs are designed to target specific cancer cells and block their growth. Immunotherapy drugs are used to boost the body’s natural immune system to fight cancer cells.
Some of the major companies in the Colon Cancer Drugs market include Bristol-Myers Squibb, Merck & Co., Pfizer, AstraZeneca, and Eli Lilly. These companies are involved in the research, development, and marketing of drugs used to treat colon cancer. Show Less Read more